Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections

被引：15

作者：

Claros, Marina ^{[1
]}

Citron, Diane M. ^{[2
]}

Goldstein, Ellie J. C. ^{[2
,3
]}

Merriam, C. Vreni ^{[2
]}

Tyrrell, Kerin L. ^{[2
]}

机构：

[1] Roche Diagnost Int AG, Rotkreuz, Switzerland

[2] R M Alden Res Lab, Culver City, CA 90230 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2013年 / 76卷 / 04期

关键词：

Anaerobes; Diabetic foot infection; Intra-abdominal infection; Resistance; Finegoldia magna; Bacteroides fragilis; Levofloxacin; Ertapenem; CARBAPENEMS; RESISTANCE;

D O I：

10.1016/j.diagmicrobio.2013.04.025

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Few labs isolate and perform susceptibility tests on anaerobes; therefore, we studied the differences between 1185 anaerobes isolated from complicated intra-abdominal infections and 470 isolated from moderate to severe diabetic foot infections. They differed markedly in the distribution of species, including Bacteroides fragilis and anaerobic Gram-positive cocci, as well as in resistance patterns, especially to fluoroquinolones. (c) 2013 Elsevier Inc. All rights reserved.

引用

页码：546 / 548

页数：3

共 50 条

[41] Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010
Babinchak, Tim
Badal, Robert
Hoban, Daryl
Hackel, Meredith
Hawser, Stephen
Lob, Sibylle
Bouchillon, Samuel
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (03) : 379 - 381
[42] Antimicrobial therapy for intra-abdominal infections :: Guidelines from the Infectious Disease Advisory Board (IDAB)
Laterre, PF
Colardyn, E
Delmée, M
De Waele, J
Legrand, JC
Van Eldere, J
Vergison, A
Vogelaers, D
ACTA CHIRURGICA BELGICA, 2006, 106 (01) : 2 - 21
[43] Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria
T Herzog
AM Chromik
W Uhl
European Journal of Medical Research, 15
[44] TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS IN THE ERA OF MULTI-DRUG RESISTANT BACTERIA
Herzog, T.
Chromik, A. M.
Uhl, W.
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (12) : 525 - 532
[45] Spectral and Antibiotic Susceptibility of Pathogens Isolated from Saudi Patients with Diabetic Foot Infections
Al-Mijalli, Samiah Hamad S.
MICROBIOLOGY RESEARCH, 2021, 12 (01) : 16 - 20
[46] Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections
Hidalgo, Jose A.
Vinluan, Celeste M.
Antony, Nishaal
DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2379 - 2386
[47] The use of ceftolozane-tazobactam in the treatment of complicated intra-abdominal infections and complicated urinary tract infections-A meta-analysis of randomized controlled trials
Cheng, I-Ling
Chen, Yu-Hung
Lai, Chih-Cheng
Tang, Hung-Jen
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (02)
[48] Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials
Mu, Y. P.
Liu, R. L.
Wang, L. Q.
Deng, X.
Zhu, N.
Wei, M. D.
Wang, Y.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (02) : 210 - 217
[49] In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011
Hoban, Daryl J.
Badal, Robert
Bouchillon, Sam
Hackel, Meredith
Kazmierczak, Krystyna
Lascols, Christine
Hawser, Stephen
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 79 (03) : 367 - 372
[50] Burden of Complicated Intra-Abdominal Infections in Children in Nigeria: Recent Experience and Systematic Review
Seyi-Olajide, Justina Onyioza
Ezidiegwu, Ugochukwu
Ameh, Emmanuel Adoyi
SURGICAL INFECTIONS, 2020, 21 (06) : 501 - 508

← 1 2 3 4 5 →